Efficacy and safety of oral misoprostol vs transvaginal balloon catheter for labor induction: An observational study within the SWEdish Postterm Induction Study (SWEPIS)
- PMID: 33768520
- DOI: 10.1111/aogs.14155
Efficacy and safety of oral misoprostol vs transvaginal balloon catheter for labor induction: An observational study within the SWEdish Postterm Induction Study (SWEPIS)
Abstract
Introduction: Induction of labor is increasing. A common indication for induction of labor is late term and postterm pregnancy at 41 weeks or more. We aimed to evaluate if there are any differences regarding efficacy, safety, and women's childbirth experience between oral misoprostol and transvaginal balloon catheter for cervical ripening in women with a low-risk singleton pregnancy and induction of labor at 41+0 to 42+0 to 1 weeks of gestation.
Material and methods: In this observational study, based on data from the Swedish Postterm Induction Study (SWEPIS), a multicenter randomized controlled trial, a total of 1213 women with a low-risk singleton pregnancy at 41 to 42 weeks of gestation were induced with oral misoprostol (n = 744) or transvaginal balloon catheter (n = 469) at 15 Swedish delivery hospitals. The primary efficacy outcome was vaginal delivery within 24 h and primary safety outcomes were neonatal and maternal composite adverse outcomes. Secondary outcomes included time to vaginal delivery and mode of delivery. Women's childbirth experience was assessed with the Childbirth Experience Questionnaire (CEQ 2.0) and visual analog scale. We present crude and adjusted mean differences and relative risks (RR) with 95% CI. Adjustment was performed for a propensity score based on delivery hospital and baseline characteristics including Bishop score.
Results: Vaginal delivery within 24 h was significantly lower in the misoprostol group compared with the balloon catheter group (46.5% [346/744] vs 62.7% [294/469]; adjusted RR 0.76 95% CI 0.640.89]). Primary neonatal and maternal safety outcomes did not differ between groups (neonatal composite 3.5% [36/744] vs 3.2% [15/469]; adjusted RR 0.77 [95% CI 0.31-1.89]; maternal composite 2.3% [17/744] vs 1.9% [9/469]; adjusted RR 1.70 [95% CI 0.58-4.97]). Adjusted mean time to vaginal delivery was increased by 3.8 h (95% CI 1.3-6.2 h) in the misoprostol group. Non-operative vaginal delivery and cesarean delivery rates did not differ. Women's childbirth experience was positive overall and similar in both groups.
Conclusions: Induction of labor with oral misoprostol compared with a transvaginal balloon catheter was associated with a lower probability of vaginal delivery within 24 h and a longer time to vaginal delivery. However, primary safety outcomes, non-operative vaginal delivery, and women's childbirth experience were similar in both groups. Therefore, both methods can be recommended in women with low-risk postdate pregnancies.
Keywords: humans; labor induction; misoprostol; mothers/psychology; pregnancy outcome; pregnancy prolonged.
© 2021 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Similar articles
-
Comparison of primiparous women's childbirth experience in labor induction with cervical ripening by balloon catheter or oral misoprostol - a prospective study using a validated childbirth experience questionnaire (CEQ) and visual analogue scale (VAS).Acta Obstet Gynecol Scand. 2022 Oct;101(10):1153-1162. doi: 10.1111/aogs.14433. Epub 2022 Aug 7. Acta Obstet Gynecol Scand. 2022. PMID: 35933726 Free PMC article.
-
Transcervical Foley Balloon Plus Vaginal Misoprostol versus Vaginal Misoprostol Alone for Cervical Ripening in Nulliparous Obese Women: A Multicenter, Randomized, Comparative-Effectiveness Trial.Am J Perinatol. 2021 Aug;38(S 01):e123-e128. doi: 10.1055/s-0040-1708805. Epub 2020 Apr 16. Am J Perinatol. 2021. PMID: 32299108 Clinical Trial.
-
Induction of labor at term with vaginal misoprostol or a prostaglandin E2 pessary: a noninferiority randomized controlled trial.Am J Obstet Gynecol. 2021 Nov;225(5):542.e1-542.e8. doi: 10.1016/j.ajog.2021.04.226. Epub 2021 Apr 19. Am J Obstet Gynecol. 2021. PMID: 33887241 Clinical Trial.
-
Misoprostol combined with cervical single or double balloon catheters versus misoprostol alone for labor induction of singleton pregnancies: a meta-analysis of randomized trials.J Matern Fetal Neonatal Med. 2020 Oct;33(20):3453-3468. doi: 10.1080/14767058.2019.1574741. Epub 2019 Feb 10. J Matern Fetal Neonatal Med. 2020. PMID: 30741051
-
Inpatient vaginal dinoprostone vs outpatient balloon catheters for cervical ripening in induction of labor: An individual participant data meta-analysis of randomized controlled trials.Acta Obstet Gynecol Scand. 2025 Jun;104(6):1041-1055. doi: 10.1111/aogs.15092. Epub 2025 Mar 25. Acta Obstet Gynecol Scand. 2025. PMID: 40134109 Free PMC article. Review.
Cited by
-
Sublingual misoprostol vs. oral misoprostol solution for induction of labor: A retrospective study.Front Surg. 2022 Sep 15;9:968372. doi: 10.3389/fsurg.2022.968372. eCollection 2022. Front Surg. 2022. PMID: 36189381 Free PMC article.
-
Women satisfaction on choosing the cervical ripening method: Oral misoprostol versus balloon catheter.Eur J Obstet Gynecol Reprod Biol X. 2023 Jun 16;19:100202. doi: 10.1016/j.eurox.2023.100202. eCollection 2023 Sep. Eur J Obstet Gynecol Reprod Biol X. 2023. PMID: 37426940 Free PMC article.
-
Maternal postpartum infection risk following induction of labor: A Danish national cohort study.Acta Obstet Gynecol Scand. 2025 Feb;104(2):309-318. doi: 10.1111/aogs.15035. Epub 2024 Dec 31. Acta Obstet Gynecol Scand. 2025. PMID: 39737539 Free PMC article.
-
Comparison of primiparous women's childbirth experience in labor induction with cervical ripening by balloon catheter or oral misoprostol - a prospective study using a validated childbirth experience questionnaire (CEQ) and visual analogue scale (VAS).Acta Obstet Gynecol Scand. 2022 Oct;101(10):1153-1162. doi: 10.1111/aogs.14433. Epub 2022 Aug 7. Acta Obstet Gynecol Scand. 2022. PMID: 35933726 Free PMC article.
-
Clinical comparison of vaginal misoprostol combined with a foley balloon versus vaginal misoprostol alone for inducing labor: a prospective cohort study.BMC Pregnancy Childbirth. 2025 Mar 15;25(1):295. doi: 10.1186/s12884-025-07375-9. BMC Pregnancy Childbirth. 2025. PMID: 40089692 Free PMC article.
References
REFERENCES
-
- Seijmonsbergen-Schermers AE, van den Akker T, Rydahl E, et al. Variations in use of childbirth interventions in 13 high-income countries: a multinational cross-sectional study. PLoS Medicine. 2020;17:e1003103.
-
- WHO. WHO Recommendations: Induction of Labour at or Beyond Term. Geneva: World Health Organisation; 2018.
-
- NICE. Induction of labour: new NICE quality standard. Midwives. 2014;17:8.
-
- Alkmark M, Berglin L, Dencker A, et al. Igångsättning av förlossning vid 41 eller 42 fullgångna graviditetsveckor. [Induction of labour at 41 or 42 weeks of gestation]. In Swedish. Göteborg: Västra Götalandsregionen, Sahlgrenska Universitetssjukhuset, HTA-centrum; 2020. Regional activity based HTA 2020:111.
-
- Keulen JKJ, Bruinsma A, Kortekaas JC, et al. Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial. BMJ. 2019;364:l344.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical